Objective Assessment of Physiologic Alterations Associated With Hemodynamically Significant Patent Ductus Arteriosus in Extremely Premature Neonates

Objective Assessment of Physiologic Alterations Associated With Hemodynamically Significant Patent Ductus Arteriosus in Extremely Premature Neonates

Delay in closure of ductus arteriosus in postnatal life may lead to serious consequences and complications in an extremely premature neonate secondary to hemodynamic alterations in regional blood flow pattern in various organs. Despite the widespread recognition amongst neonatologists to identify a...

Full description

Bibliographic Details
Main Authors:	Aparna Patra, Pratibha S. Thakkar, Majd Makhoul, Henrietta S. Bada
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Pediatrics
Subjects:	hsPDA preterm physiologic echocardiogram near-infrared spectroscopy electrical cardiometry
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2021.648584/full

Similar Items

Obstacles to the Early Diagnosis and Management of Patent Ductus Arteriosus
by: Gowda SH, et al.
Published: (2024-02-01)

Ligation of patent ductus arteriosus in very low birth weight premature infants
by: Hasan F. Othman, et al.
Published: (2020-08-01)

Gentamicin in neonates with hemodynamically significant patent ductus arteriosus
by: Kannan Sridharan, et al.
Published: (2023-01-01)

Decreased plasma levels of PDGF-BB, VEGF-A, and HIF-2α in preterm infants after ibuprofen treatment
by: Xuemei Huang, et al.
Published: (2022-07-01)

Baseline cardiac output and its alterations during ibuprofen treatment for patent ductus arteriosus in preterm infants
by: Kai-Hsiang Hsu, et al.
Published: (2019-06-01)

Echocardiographic Diagnosis and Hemodynamic Evaluation of Patent Ductus Arteriosus in Extremely Low Gestational Age Newborn (ELGAN) Infants
by: Yogen Singh, et al.
Published: (2020-11-01)

Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus
by: Lilian S.R. Sadeck, et al.
Published: (2014-11-01)

Personalized Evidence-Based Management of Patent Ductus Arteriosus in Preterm Infants
by: Belinda Chan, et al.
Published: (2023-12-01)

Serial serum brain-type natriuretic peptide (BNP) identifies compromised blood flow in infants with hemodynamically significant patent ductus arteriosus
by: Yasser Elsayed, et al.
Published: (2017-08-01)

Correlation between the Closure Time of Patent Ductus Arteriosus in Preterm Infants and Long-Term Neurodevelopmental Outcome
by: Natsumi Kikuchi, et al.
Published: (2024-01-01)

Patent Ductus Arteriosus Device Closure with AMPLATZER Duct Occluder-II in a Low Birth Weight Preterm Neonate- First Experience in Pakistan
by: Sana Imtiaz, et al.
Published: (2023-05-01)

Management of Patent Ductus Arteriosus in Premature Infants in 2020
by: Sarah Parkerson, et al.
Published: (2021-02-01)

Early prediction of spontaneous Patent Ductus Arteriosus (PDA) closure and PDA-associated outcomes: a prospective cohort investigation
by: Jonathan L. Slaughter, et al.
Published: (2019-09-01)

Transport and Anaesthesia Consideration for Transcatheter Patent Ductus Arteriosus Closure in Premature Infants
by: Tuan Chen Aw, et al.
Published: (2023-09-01)

Modern treatment of patent ductus arteriosus – single center experience
by: Senka Mesihović Dinarević, et al.
Published: (2014-12-01)

Baby-OSCAR: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies—a statistical analysis plan for short-term outcomes
by: Jennifer L. Bell, et al.
Published: (2021-05-01)

Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams
by: Alain Fraisse, et al.
Published: (2020-09-01)

Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus
by: Janardhan Mydam, et al.
Published: (2019-08-01)

The effects of WeChat follow-up management to improve the parents’ mental status and the quality of life of premature newborns with patent ductus arteriosus
by: Bin Yang, et al.
Published: (2021-08-01)

Device closure of patent ductus arteriosus in interrupted inferior vena cava
by: Neeraj Aggarwal, et al.
Published: (2015-12-01)

Transcatheter device closure of patent ductus arteriosus without arterial access – Single institution experience
by: Gaurav Garg, et al.
Published: (2013-09-01)

Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data
by: Flaminia Bardanzellu, et al.
Published: (2020-12-01)

Evaluating the Clinical Course of Patent Ductus Arteriosus after Discharge and Comparing in Therapies Techniques
by: Noor Mohammad Noori, et al.
Published: (2017-05-01)

Patent Ductus Arteriosus (P.D.A.) (An analysis of 37 surgically proved cases)
by: O. J. Rachman, et al.
Published: (2019-09-01)

Tetralogy of Fallot with right ventricular outflow tract obstruction and patent ductus arteriosus in a dog
by: Seungjo Park, et al.
Published: (2020-07-01)

Ibuprofen and paracetamol for patent ductus arteriosus
by: Carlo Dani
Published: (2014-09-01)

REVERSE PDA – LESS COMMON TYPE OF PATENT DUCTUS ARTERIOSUS -CASE REPORT
by: Iuliu Scurtu, et al.
Published: (2016-11-01)

Evaluation of Alacepril Administration in Canine Patent Ductus Arteriosus According to Plasma Chymase Activity
by: Kazumi Shimada, et al.
Published: (2024-04-01)

PDA management in preterm infants: keep your hands off the ductus!
by: Paolo Giliberti, et al.
Published: (2014-10-01)

The strategy of paracetamol (acetaminophen) use in closing patent ductus arteriosus in premature neonates.
by: Khaleel I. ALSuwayfee
Published: (2016-10-01)

Prophylaxis of Patent Ductus Arteriosus with Paracetamol in Extremely Low Gestational Age Newborns (ELGANs): A Single-Institution Observational Study in Vietnam
by: Tinh Thu Nguyen, et al.
Published: (2023-12-01)

Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety
by: Haşim Olgun, et al.
Published: (2017-02-01)

The impact of the route of administration on the efficacy and safety of the drug therapy for patent ductus arteriosus in premature infants: a systematic review and meta-analysis
by: Hanwen Luo, et al.
Published: (2024-01-01)

The effects of ductal size on the severity of pulmonary hypertension in children with patent ductus arteriosus (PDA): a multi-center study
by: Josephat M. Chinawa, et al.
Published: (2021-03-01)

Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates
by: Mehdi Ghaderian, et al.
Published: (2019-01-01)

Patent ductus arteriosus with persistent pulmonary artery hypertension after transcatheter closure
by: Feng JQ, et al.
Published: (2016-11-01)

Prevalence of patent ductus arteriosus in premature infants at the Neonatal Ward, Cipto Mangunkusumo Hospital, Jakarta
by: Benita Deselina, et al.
Published: (2016-10-01)

Myocardial injury and inflammatory response in percutaneous device closures of pediatric patent ductus arteriosus
by: Zeng-Rong Luo, et al.
Published: (2022-05-01)

Transcatheter Closure of Patent Ductus Arteriosus in Premature Infants With Very Low Birth Weight
by: Jieh-Neng Wang, et al.
Published: (2021-01-01)

Transcatheter closure in preterm infants with patent ductus arteriosus: feasibility, results, hemodynamic monitoring and future prospectives
by: Gaia Francescato, et al.
Published: (2023-11-01)